PATENT CLAIM ANALYSIS

Application Number: 16090380
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["514", "292000"]

Abstract:
Described herein are compounds that can bind CaSR and/or a CaSR extracellular domain and formulations thereof. Also described herein are methods of inhibiting CaSR and/or treating a disease or disorder associated with a mutation in CaSR by administering a compound or formulation thereof described herein. Also described herein are assays that can be used to identify compounds that can bind an extracellular domain of CaSR.

Claim (Index 56):
The method of  claim 53 , wherein the amount of TCNA administered decreases the activity of a CaSR.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.74359
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15517409', '15665788', '11456712', '12993783', '12612518']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6881380573523442
- 35 USC 102 Novelty (BERT): 0.5262185578309553
- Combined Prediction Score: 0.6719461074002053
- Mean Citation Score: 174.502284
- Max Citation Score: 183.73915
- Similarity Product: 89.06577926787884

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test